Bacillus Anthracis Strain V770-NP1-R Filtrate (attenuated) Antigen Uses, Dosage, Side Effects and more
Bacillus Anthracis Strain V770-NP1-R Filtrate (attenuated) Antigen is a vaccine used for the pre- or post-exposure prophylaxis of disease in at high risk of, suspected or confirmed exposure to Bacillus anthracis. It is subcutaneously or intramuscularly administered. It is derived from cell-free filtrates of microaerophilic cultures of an avirulent, nonencapsulated strain of Bacillus anthracis which are grown in a chemically defined protein-free medium [FDA Label].
| Trade Name | Bacillus Anthracis Strain V770-NP1-R Filtrate (attenuated) Antigen |
| Generic | Anthrax vaccine |
| Anthrax vaccine Other Names | Anthrax vaccine adsorbed, Bacillus anthracis inactivated antigen, Bacillus anthracis strain V770-NP1-R antigen, Bacillus anthracis strain V770-NP1-R antigens, Bacillus anthracis strain V770-NP1-R filtrate (attenuated) antigen, Bacillus anthracis strain V770-NP1-R filtrate antigen |
| Type | |
| Groups | Approved |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
